| Ticker: | RYTM |
| Current Price: | $115.02 |
| % Daily Change: | 4.70% |
| Volume (1,000s): | 1,144.11 |
| Average Volume (1,000s): | 801.21 |
| Market Cap (M): | $7,974.44 |
| 1/2/2024 Price: | $45.97 |
| Change Since Inception: | 150.21% |
Rhythm Pharmaceuticals, Inc.
222 Berkeley Street
12th Floor
Boston, MA 02116
United States
Rhythm is a biopharmaceutical company aimed at developing and commercializing therapies for the treatment of rare MC4R pathway diseases. The company is leveraging the Rhythm Engine — comprised of its TEMPO Registry, GO-ID genotyping study and Uncovering Rare Obesity program — to improve the understanding, diagnosis and potentially the treatment of these disorders. For healthcare professionals, visit www.RareObesity.com for more information. For patients and caregivers, visit www.LEADforRareObesity.com for more information.